Results 121 to 130 of about 8,289 (149)

When Atypical Becomes Typical: A Fulminant Seronegative Anti-GBM Disease. [PDF]

open access: yesKidney Med
Andrawes-Barbara FY   +4 more
europepmc   +1 more source

Urinary cell cycle arrest biomarkers TIMP-2 and IGFBP7 for the assessment of acute kidney injury in dogs with pyometra. [PDF]

open access: yesFront Vet Sci
Braz LADN   +8 more
europepmc   +1 more source

Familial membranoproliferative glomerulonephritis

Nephrology Dialysis Transplantation, 1995
Abstract Four and two male sibs of two separate families who had biopsy-proven membranoproliferative glomerulonephritis (MPGN) are presented. In the first family four sibs of the first-degree consanguineous marriage showed the clinical picture of nephrotic syndrome without hypocomplementaemia at initial laboratory findings.
A, Bakkaloglu   +4 more
openaire   +2 more sources

Idiopathic Membranoproliferative Glomerulonephritis

Annual Review of Medicine, 1980
Idiopathic membranoproliferative glomerulonephritis (MPGN) is one iden­ tifiable form of chronic nephritis characterized by distinctive glomerular morphology. However, it is not known whether MPGN is a single patho­ genetic entity. It was originally recognized as one type of chronic glomerulonephritis with persistent hypocomplementemia by West et al (1)
Y, Kim, A F, Michael
openaire   +2 more sources

Membranoproliferative Glomerulonephritis in Pregnancy

The American Journal of the Medical Sciences, 2017
Membranoproliferative glomerulonephritis (MPGN) is an uncommon form of glomerulonephritis and it can be particularly difficult to predict outcomes and manage women with this disorder during pregnancy.The management of 3 successful pregnancies in women with MPGN from 1 center and previously described cases from the world literature are reviewed.
Devika, Nair   +2 more
openaire   +2 more sources

Immunosuppressive Treatment of Membranoproliferative Glomerulonephritis

Nephron, 2008
The treatment of membranoproliferative glomerulonephritis (MPGN) is considered by most authors as unrewarding, and the disease progresses to end-stage renal disease (ESRD). We studied the effectiveness of a new immunosuppressive (IS) regimen by analyzing the rates of remission, relapse and progression to ESRD in 19 patients with MPGN.
FAEDDA R   +4 more
openaire   +5 more sources

Membranoproliferative glomerulonephritis and amyloidosis

Human Pathology, 1984
The first known case of membranoproliferative glomerulonephritis co-existing with amyloidosis is reported. The question of whether the amyloidosis was secondary to the glomerulonephritis or whether primary amyloidosis co-existed with membranoproliferative glomerulonephritis is addressed.
openaire   +2 more sources

Home - About - Disclaimer - Privacy